Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Beverly Jieu

1PUBLICATIONS
14CO-AUTHORS
Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Aug 25, 2024
Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.

Timothy A Couttas, Carola Boost, Franziska Pahlisch

Pageof 1

Frequent Collaborators

1 joint publications

Timothy A Couttas

1 joint publications

Franziska Pahlisch

1 joint publications

Eliska B Sykorova

1 joint publications

Juliane K Mueller

1 joint publications

Judith E Leweke

1 joint publications

Inga Dammann

1 joint publications

Anna E Hoffmann

1 joint publications

Oliver Grimm

1 joint publications

Frank Enning

1 joint publications

Herta Flor

Frequent Collaborators

1 joint publications

Timothy A Couttas

1 joint publications

Franziska Pahlisch

1 joint publications

Eliska B Sykorova

1 joint publications

Juliane K Mueller

Top Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:25

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on : Feb 28, 2025

180
See more related videos

Top Related Videos

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
05:25

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes

Published on : Feb 28, 2025

180
See more related videos